Fidia Pharma USA Inc. HOME PAGE THE COMPANY PRODUCT PORTFOLIO PRESS RELEASES & EVENTS CAREERS CONTACT US DON’T LET PAIN PUT YOUR LIFE ON HOLD Recognized as a global leader in hyaluronic acid technology, and for always pioneering what’s next, Fidia offers patients much more than pain relief solutions – we offer hope to live better. FIND OUT MORE OUR PRODUCTS The industry’s only 2-injection hyaluronic acid treatment for osteoarthritis (OA) knee pain VISIT SITE A 3-injection hyaluronic acid treatment for osteoarthritis (OA) knee pain VISIT SITE The original safe, proven hyaluronic acid treatment for osteoarthritis (OA) knee pain VISIT SITE An acellular, shelf-stable, amniotic membrane-derived injectable allograft, which retains rich intrinsic beneficial properties of the amniotic membrane VISIT SITE NEW from Fidia Pharma USA Inc. Quality, consistency, and reliability—all in one cost-effective PRP system VISIT SITE Hyaluronic acid-based gel and suppositories that provide temporary relief of vaginal dryness symptoms VISIT SITE RECENT COMPANY NEWS November 3, 2021 Fidia Celebrates Its 75th Anniversary Every day we proudly celebrate the foresight and expertise of those who have helped to build the company, and recognize the vision of those who are already shaping tomorrow’s world. READ MORE August 4, 2021 Fidia announces the FDA Orphan Drug designation for ONCOFID®-P for the treatment of malignant mesothelioma, the cancer caused by exposure to asbestos Malignant mesothelioma is a rare and aggressive cancer with limited therapeutic options. READ MORE March 30, 2021 Fidia Farmaceutici Continues On Its Growth Path Fidia signed a binding agreement with Sanofi for the acquisition of a portfolio of anti-inflammatory drugs. READ MORE VISIT OUR CORPORATE WEBSITE FIDIA FARMACEUTICI S.P.A. FIDIA'S OTHER WEBSITES Direct link to: hyalgan.com hyalogyn.com hymovis.com nudynus.com triluron.com FOLLOW US KEY BUSINESS AREAS Drawing on the strengths of the parent company, our product portfolio focuses primarily on therapeutic areas such as joint healthcare and women's health. Fidia Pharma USA is focused on providing unique, innovative and reliable Hyaluronic Acid (HA)-based treatment options. © 2021 Fidia Pharma USA Inc. Fidia Farmaceutici S.p.A was founded in 1946, and Fidia Pharma USA Inc. is a wholly owned subsidiary. This site is intended for use by US residents only. LEGAL TERMS PRIVACY POLICY COPYRIGHT

This website is aimed solely and exclusively at healthcare professionals. To access the web page, click YES, if you are a healthcare professional. If you are not a healthcare professional, select NO to exit. YES NO ITA | ENG BEGINNING ABOUT FIDIA PRODUCTS NEWS EVENTS PATIENT INFORMATION HEALTH PROFESSIONALS CONTACT OUR VALUES: QUALITY, COMPETITIVENESS, INNOVATION, INTERNATIONALIZATION The experience of yesterday under the immediate reality of today. Read more We use cookies to offer you the best experience on our website. You can learn more about which cookies we use or disable them in the settings . TO ACCEPT TO REFUSE SET UP